MicroBase Technology Corp. provides drug delivery systems to patients and healthcare professionals.
Price History & Performance
|Historical stock prices|
|Current Share Price||NT$13.00|
|52 Week High||NT$10.85|
|52 Week Low||NT$20.85|
|1 Month Change||4.84%|
|3 Month Change||13.04%|
|1 Year Change||-33.33%|
|3 Year Change||-51.58%|
|5 Year Change||-35.61%|
|Change since IPO||-0.51%|
Recent News & Updates
|3184||TW Medical Equipment||TW Market|
Return vs Industry: 3184 underperformed the TW Medical Equipment industry which returned 10.8% over the past year.
Return vs Market: 3184 underperformed the TW Market which returned 39% over the past year.
Stable Share Price: 3184 is more volatile than 75% of TW stocks over the past 3 months, typically moving +/- 8% a week.
Volatility Over Time: 3184's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of TW stocks.
About the Company
MicroBase Technology Corp. provides drug delivery systems to patients and healthcare professionals. It specializes in Laser LIGA, a non-silicon-based micromachining technology that is used in the manufacture and development of miniaturized devices and micron-scale parts. The company provides vibrating mesh nebulizers under the Pocket Air name for the home care and hospital sectors; and micro-infusion skin care products under the PharMatrix name.
MicroBase Technology Fundamentals Summary
|3184 fundamental statistics|
Is 3184 overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|3184 income statement (TTM)|
|Cost of Revenue||NT$154.63m|
Last Reported Earnings
Jun 30, 2021
Next Earnings Date
|Earnings per share (EPS)||-0.65|
|Net Profit Margin||-21.93%|
How did 3184 perform over the long term?See historical performance and comparison
Is MicroBase Technology undervalued compared to its fair value and its price relative to the market?
Price to Book (PB) ratio
Share Price vs. Fair Value
Below Fair Value: Insufficient data to calculate 3184's fair value to establish if it is undervalued.
Significantly Below Fair Value: Insufficient data to calculate 3184's fair value to establish if it is undervalued.
Price To Earnings Ratio
PE vs Industry: 3184 is unprofitable, so we can't compare its PE Ratio to the TW Medical Equipment industry average.
PE vs Market: 3184 is unprofitable, so we can't compare its PE Ratio to the TW market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate 3184's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: 3184 is good value based on its PB Ratio (1.9x) compared to the TW Medical Equipment industry average (2x).
How is MicroBase Technology forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Forecasted Healthcare industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as MicroBase Technology has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
How has MicroBase Technology performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: 3184 is currently unprofitable.
Growing Profit Margin: 3184 is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: 3184 is unprofitable, but has reduced losses over the past 5 years at a rate of 28.8% per year.
Accelerating Growth: Unable to compare 3184's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 3184 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (9.5%).
Return on Equity
High ROE: 3184 has a negative Return on Equity (-9.7%), as it is currently unprofitable.
How is MicroBase Technology's financial position?
Financial Position Analysis
Short Term Liabilities: 3184's short term assets (NT$366.9M) exceed its short term liabilities (NT$108.4M).
Long Term Liabilities: 3184's short term assets (NT$366.9M) exceed its long term liabilities (NT$58.0M).
Debt to Equity History and Analysis
Debt Level: 3184's debt to equity ratio (23.9%) is considered satisfactory.
Reducing Debt: 3184's debt to equity ratio has increased from 13.2% to 23.9% over the past 5 years.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 3184 has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: 3184 has sufficient cash runway for more than 3 years if free cash flow continues to grow at historical rates of 4.7% each year
What is MicroBase Technology current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate 3184's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate 3184's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if 3184's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if 3184's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: 3184 is not paying a notable dividend for the TW market.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of 3184's dividend in 3 years as they are not forecast to pay a notable one for the TW market.
How experienced are the management team and are they aligned to shareholders interests?
MicroBase Technology has no CEO, or we have no data on them.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
MicroBase Technology Corp.'s employee growth, exchange listings and data sources
- Name: MicroBase Technology Corp.
- Ticker: 3184
- Exchange: TPEX
- Founded: 1997
- Industry: Health Care Equipment
- Sector: Healthcare
- Market Cap: NT$1.044b
- Shares outstanding: 80.27m
- Website: https://www.microbase.com.tw
- MicroBase Technology Corp.
- No. 756, Jiadong Road
- Bade District
- Taoyuan City
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/09/24 08:33|
|End of Day Share Price||2021/09/23 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.